Kirsten Bryant is a research scientist and Assistant Professor of Pharmacology at the University of North Carolina at Chapel Hill School of Medicine. The Bryant lab performs research that is focused on pancreatic cancer biology and developing improved treatments for pancreatic cancer patients.

Dr. Bryant has received a MERIT award from the National Cancer Institute, as well as additional research funding from the American Association of Cancer Researchers and the Pancreatic Cancer Action Network. Dr. Bryant is one of only seven recipients of the inaugural Pancreatic Cancer Action Network Therapeutic Accelerator Collaborative Award. In 2020, she received a Scholar Award from the William Guy Forbeck Research Foundation and in 2019 received the Joseph S. Pagano Award.

As a lead researcher, Dr. Bryant has contributed many articles to the scientific literature and serves as a reviewer for several scientific journals. She is a member of the Scientific Advisory Committee for the Sky Pancreatic Research Foundation. She has also spoken at many scientific symposiums focused on pancreatic cancer, RAS biology, and cancer metabolism.

In addition to her research, Dr. Bryant is passionate about mentoring younger scientists and is committed to community outreach. She has led large-scale laboratory tours for groups of pancreatic cancer patients and their families to better understand how their contributions have impacted cancer research.

Dr. Bryant considers herself a dedicated pancreatic cancer biologist who has had success translating academic research into the clinic, securing research funding and mentoring future scientists.

Kirsten Bryant is a 2003 Conrad Weiser High School graduate, a 2007 graduate of Bucknell University, and she received her Ph D from Cornell University in 2013.

Conrad Weiser Area School District